Copyright Reports & Markets. All rights reserved.

Global Healthcare Nanotechnology Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Healthcare Nanotechnology Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Nanomedicine
      • 1.4.3 Nano Medical Devices
      • 1.4.4 Nano Diagnosis
      • 1.4.5 Other
    • 1.5 Market by Application
      • 1.5.1 Global Healthcare Nanotechnology Market Share by Application (2014-2025)
      • 1.5.2 Anticancer
      • 1.5.3 CNS Product
      • 1.5.4 Anti-infective
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Healthcare Nanotechnology Market Size
    • 2.2 Healthcare Nanotechnology Growth Trends by Regions
      • 2.2.1 Healthcare Nanotechnology Market Size by Regions (2014-2025)
      • 2.2.2 Healthcare Nanotechnology Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Healthcare Nanotechnology Market Size by Manufacturers
      • 3.1.1 Global Healthcare Nanotechnology Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Healthcare Nanotechnology Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Healthcare Nanotechnology Market Concentration Ratio (CR5 and HHI)
    • 3.2 Healthcare Nanotechnology Key Players Head office and Area Served
    • 3.3 Key Players Healthcare Nanotechnology Product/Solution/Service
    • 3.4 Date of Enter into Healthcare Nanotechnology Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Healthcare Nanotechnology Market Size by Type (2014-2019)
    • 4.2 Global Healthcare Nanotechnology Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Healthcare Nanotechnology Market Size (2014-2019)
    • 5.2 Healthcare Nanotechnology Key Players in United States
    • 5.3 United States Healthcare Nanotechnology Market Size by Type
    • 5.4 United States Healthcare Nanotechnology Market Size by Application

    6 Europe

    • 6.1 Europe Healthcare Nanotechnology Market Size (2014-2019)
    • 6.2 Healthcare Nanotechnology Key Players in Europe
    • 6.3 Europe Healthcare Nanotechnology Market Size by Type
    • 6.4 Europe Healthcare Nanotechnology Market Size by Application

    7 China

    • 7.1 China Healthcare Nanotechnology Market Size (2014-2019)
    • 7.2 Healthcare Nanotechnology Key Players in China
    • 7.3 China Healthcare Nanotechnology Market Size by Type
    • 7.4 China Healthcare Nanotechnology Market Size by Application

    8 Japan

    • 8.1 Japan Healthcare Nanotechnology Market Size (2014-2019)
    • 8.2 Healthcare Nanotechnology Key Players in Japan
    • 8.3 Japan Healthcare Nanotechnology Market Size by Type
    • 8.4 Japan Healthcare Nanotechnology Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Healthcare Nanotechnology Market Size (2014-2019)
    • 9.2 Healthcare Nanotechnology Key Players in Southeast Asia
    • 9.3 Southeast Asia Healthcare Nanotechnology Market Size by Type
    • 9.4 Southeast Asia Healthcare Nanotechnology Market Size by Application

    10 India

    • 10.1 India Healthcare Nanotechnology Market Size (2014-2019)
    • 10.2 Healthcare Nanotechnology Key Players in India
    • 10.3 India Healthcare Nanotechnology Market Size by Type
    • 10.4 India Healthcare Nanotechnology Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Healthcare Nanotechnology Market Size (2014-2019)
    • 11.2 Healthcare Nanotechnology Key Players in Central & South America
    • 11.3 Central & South America Healthcare Nanotechnology Market Size by Type
    • 11.4 Central & South America Healthcare Nanotechnology Market Size by Application

    12 International Players Profiles

    • 12.1 Amgen
      • 12.1.1 Amgen Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Healthcare Nanotechnology Introduction
      • 12.1.4 Amgen Revenue in Healthcare Nanotechnology Business (2014-2019)
      • 12.1.5 Amgen Recent Development
    • 12.2 Teva Pharmaceuticals
      • 12.2.1 Teva Pharmaceuticals Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Healthcare Nanotechnology Introduction
      • 12.2.4 Teva Pharmaceuticals Revenue in Healthcare Nanotechnology Business (2014-2019)
      • 12.2.5 Teva Pharmaceuticals Recent Development
    • 12.3 Abbott
      • 12.3.1 Abbott Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Healthcare Nanotechnology Introduction
      • 12.3.4 Abbott Revenue in Healthcare Nanotechnology Business (2014-2019)
      • 12.3.5 Abbott Recent Development
    • 12.4 UCB
      • 12.4.1 UCB Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Healthcare Nanotechnology Introduction
      • 12.4.4 UCB Revenue in Healthcare Nanotechnology Business (2014-2019)
      • 12.4.5 UCB Recent Development
    • 12.5 Roche
      • 12.5.1 Roche Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Healthcare Nanotechnology Introduction
      • 12.5.4 Roche Revenue in Healthcare Nanotechnology Business (2014-2019)
      • 12.5.5 Roche Recent Development
    • 12.6 Celgene
      • 12.6.1 Celgene Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Healthcare Nanotechnology Introduction
      • 12.6.4 Celgene Revenue in Healthcare Nanotechnology Business (2014-2019)
      • 12.6.5 Celgene Recent Development
    • 12.7 Sanofi
      • 12.7.1 Sanofi Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Healthcare Nanotechnology Introduction
      • 12.7.4 Sanofi Revenue in Healthcare Nanotechnology Business (2014-2019)
      • 12.7.5 Sanofi Recent Development
    • 12.8 Merck & Co
      • 12.8.1 Merck & Co Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Healthcare Nanotechnology Introduction
      • 12.8.4 Merck & Co Revenue in Healthcare Nanotechnology Business (2014-2019)
      • 12.8.5 Merck & Co Recent Development
    • 12.9 Biogen
      • 12.9.1 Biogen Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Healthcare Nanotechnology Introduction
      • 12.9.4 Biogen Revenue in Healthcare Nanotechnology Business (2014-2019)
      • 12.9.5 Biogen Recent Development
    • 12.10 Stryker
      • 12.10.1 Stryker Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Healthcare Nanotechnology Introduction
      • 12.10.4 Stryker Revenue in Healthcare Nanotechnology Business (2014-2019)
      • 12.10.5 Stryker Recent Development
    • 12.11 Gilead Sciences
    • 12.12 Pfizer
    • 12.13 3M Company
    • 12.14 Johnson & Johnson
    • 12.15 Smith & Nephew
    • 12.16 Leadiant Biosciences
    • 12.17 Kyowa Hakko Kirin
    • 12.18 Shire
    • 12.19 Ipsen
    • 12.20 Endo International

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
      Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.
      The classification of Healthcare Nanotechnology includes Nanomedicine, Nano Medical Devices, Nano Diagnosis and Other product. And the sales proportion of Nanomedicine in 2017 is about 86.5%, and the proportion is in increasing trend from 2013 to 2017.
      In 2018, the global Healthcare Nanotechnology market size was 160800 million US$ and it is expected to reach 306100 million US$ by the end of 2025, with a CAGR of 9.6% during 2019-2025.

      This report focuses on the global Healthcare Nanotechnology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Healthcare Nanotechnology development in United States, Europe and China.

      The key players covered in this study
      Amgen
      Teva Pharmaceuticals
      Abbott
      UCB
      Roche
      Celgene
      Sanofi
      Merck & Co
      Biogen
      Stryker
      Gilead Sciences
      Pfizer
      3M Company
      Johnson & Johnson
      Smith & Nephew
      Leadiant Biosciences
      Kyowa Hakko Kirin
      Shire
      Ipsen
      Endo International

      Market segment by Type, the product can be split into
      Nanomedicine
      Nano Medical Devices
      Nano Diagnosis
      Other

      Market segment by Application, split into
      Anticancer
      CNS Product
      Anti-infective
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Healthcare Nanotechnology status, future forecast, growth opportunity, key market and key players.
      To present the Healthcare Nanotechnology development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Healthcare Nanotechnology are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now